Cybin’ (CYBN.NE) subsidiary Adelia Therapeutics gets their science hat on for proof of concept
Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of… Read More »Cybin’ (CYBN.NE) subsidiary Adelia Therapeutics gets their science hat on for proof of concept









